Clinical trial
Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
NCT00307606 · Herlev Hospital, Other · Unknown status
Key facts
| NCT number | NCT00307606 |
|---|---|
| Title | Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma |
| Official title | Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma |
| Lead sponsor | Herlev Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Neoplasms, Mastectomy |
| Intervention type | Drug |
| Interventions | Solu-medrol 125 mg |
| Enrollment | 40 |
| Start date | Dec 1, 2005 |
| Completion | Dec 1, 2007 |
| First posted | Mar 28, 2006 |
| Last update posted | Sep 6, 2007 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: